Clinical Trials Browser

Phase 1/2 × Turcot syndrome × Nivolumab × Clear all

NCT06362369 2026-04-13

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

NCT02992964 2024-04-02

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Phase 1/2 Terminated

11 enrolled

Turcot syndrome